NCT04954183View on ClinicalTrials.gov

Development of an EEG Diagnostic for Alzheimer's Disease

CompletedOBSERVATIONAL

Enrollment

29

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

July 24, 2025

Study Completion Date

July 24, 2025

Conditions

Mild Cognitive ImpairmentAlzheimer DiseaseDementia With Lewy BodiesNormal Control APOE e4 Carriers and Noncarriers

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Spark Neuro Inc.

INDUSTRY

lead

Mayo Clinic

OTHER

NCT04954183 - Development of an EEG Diagnostic for Alzheimer's Disease | Biotech Hunter | Biotech Hunter